Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 77,355Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AbbVie Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AbbVie Corporation

arrow
ChemOutsourcing
Not Confirmed

AbbVie Corporation

Country
arrow
ChemOutsourcing
Not Confirmed

UPADACITINIB

Brand Name : RINVOQ

Patent Number : 2781891

Filing Date : 2010-12-01

Strength per Unit : 15 mg

Dosage Form : TABLET (EXTENDED-RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-01

Date Granted : 2018-02-13

blank

02

AbbVie Corporation

arrow
ChemOutsourcing
Not Confirmed

AbbVie Corporation

Country
arrow
ChemOutsourcing
Not Confirmed

UPADACITINIB

Brand Name : RINVOQ

Patent Number : 2781891

Filing Date : 2010-12-01

Strength per Unit : 30mg

Dosage Form : TABLET (EXTENDED-RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-01

Date Granted : 2018-02-13

blank

03

AbbVie Corporation

arrow
ChemOutsourcing
Not Confirmed

AbbVie Corporation

Country
arrow
ChemOutsourcing
Not Confirmed

UPADACITINIB

Brand Name : RINVOQ

Patent Number : 2781891

Filing Date : 2010-12-01

Strength per Unit : 45mg

Dosage Form : TABLET (EXTENDED-RELEASE)

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-12-01

Date Granted : 2018-02-13

blank